Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Clinical Trials

11 clinical trials for Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma — RECRUITING · PHASE2
• Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma — RECRUITING · PHASE2
• Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma — RECRUITING · PHASE1
• Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma — COMPLETED · PHASE2
• Camrelizumab, Pegaspargase and Apatinib With Radiation Therapy for Stage IE/IIE ENKTL — COMPLETED · NA
• Tislelizumab Combined Treatment in Refractory Extranodal NK/T-cell Lymphoma — COMPLETED · NA
• Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma — COMPLETED · PHASE2
• Anlotinib for Advanced and Refractory Natural Killer /T-cell Lymphoma — COMPLETED · PHASE2
• Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell Lymphoma — OTHER · PHASE2
• SIMPLE Chemotherapy for NK Lymphoma/Leukaemia — OTHER · PHASE3
• Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma — OTHER · PHASE2

Refine this search